| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO
1 company
Watts Ryan J. is a President And CEO at Denali Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 29 sells.
Estimated insider holdings value: $6.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2019 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 18,333 | $19.07 | $349,610.31 | -0.7% | |
| May 3, 2019 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 18,334 | $24.20 | $443,743.80 | -0.2% | |
| Apr 3, 2019 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 18,333 | $25.03 | $458,800.12 | -0.1% | |
| Mar 5, 2019 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 18,333 | $22.18 | $406,600.81 | -0.1% | |
| Feb 5, 2019 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 18,334 | $18.72 | $343,299.88 | -0.2% | |
| Jan 4, 2019 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 18,333 | $19.43 | $356,288.16 | -0.1% | |
| Dec 3, 2018 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 18,333 | $18.43 | $337,937.85 | -0.3% | |
| Nov 15, 2018 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 18,334 | $18.09 | $331,664.30 | -0.3% | |
| Oct 1, 2018 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 18,333 | $21.72 | $398,192.76 | -0.7% | |
| Sep 4, 2018 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 18,333 | $19.06 | $349,426.98 | -0.7% |